A community for people who want to remain as healthy as possible as we age.

Sugary drinks boost risk factors for heart disease, study shows

(UC Davis) Beverages sweetened with low, medium and high amounts of high-fructose corn syrup significantly increase risk factors for cardiovascular disease, even when consumed for just two weeks by young, healthy men and women, reports a team of researchers at the University of California, Davis.
The study is the first to demonstrate a direct, dose-dependent relationship between the amount of added sugar consumed in sweetened beverages and increases in specific risk factors for cardiovascular disease.
The data reinforce evidence from an earlier epidemiological study showing that the risk of death from cardiovascular disease — the leading cause of death in the United States and around the world — increases as the amount of added sugar consumed increases.
[Click the title, above, to post a comment.]

Novo Nordisk says Saxenda obesity drug to cost $1,068 per month

(Reuters) Novo Nordisk's new obesity drug Saxenda, which has been launched in the United States on Wednesday, will cost $1,068 per month in the country, the company told Reuters in an email on Wednesday.
"The amount paid by the individual patient will depend on whether Saxenda is covered by the person's health insurance," a Novo Nordisk spokesman said in the email.
Community: Why do they charge so much? Because they can.
[Click the title, above, to post a comment.]

Muscle-wasting for elderly on statin may outweigh benefits

(Daily Mail) Statins can prevent heart attacks in the elderly – but side-effects of muscle weakness and ‘brain fog’ may outweigh the benefits, warn US researchers.
Even a small increase in the risk of these problems could affect the independence of older people, particularly because they are more sensitive to the effects of drugs, it is claimed…
The study found statins could be a cheap way of preventing heart attacks, strokes and cardiovascular incidents in the elderly population in general.
Assistant professor of epidemiology Michelle Odden said: ‘Statins look promising as an intervention in this population, but there are concerns about potential physical or cognitive side-effects. It’s not all good or all bad; we’re in a grey area. 
[Click the title, above, to post a comment.]

Hepatitis B Infection 100% Eliminated With Cancer Drug Combination In Preclinical Model

(Medical Daily) A cancer drug was 100 percent successful in clearing away hepatitis B infections in preclinical models for an Australian study. If researchers successfully replicate the results in human clinical trials, the drug may become the first-ever cure to the hepatitis B virus and may serve as a model for treating other viruses, such as HIV and herpes.
Researchers at the Walter and Eliza Hall Institute in Melbourne, Australia used a combination of the cancer drug birinapant and the antiviral drug entecavir to completely eliminate hepatitis B infections in “hundreds of tests in preclinical models,” lead researcher Dr. Marc Pellegrini explained.
[Click the title, above, to post a comment.]

Could broccoli hold the key to head and neck cancer prevention?

(Medical News Today) Vegetables such as broccoli are mainly recognized as being healthful on account of their vitamins and fiber content. However, a new study suggests that broccoli sprout extract could also be protective against head and neck cancer…
Sulforaphane reduced both the incidence of oral cancer and the number of tumors that developed in the mice significantly. This finding led the researchers to test a mixture of fruit juice and broccoli sprout extract rich in sulforaphane on 10 healthy human volunteers.
No ill-effects occurred, and at the same time, the researchers detected certain protective changes in the lining of the volunteers' mouths, suggesting that the compound was absorbed and directed toward the tissue in this area.
[Click the title, above, to post a comment.]

'Very exciting' prostate cancer drug originally meant for women could cure 30% of all tumours

(The Mirror) Men with advanced and deadly prostate cancer driven by certain genetic defects may benefit from a pioneering drug originally intended for women, research has shown.
Olaparib, the first cancer drug to target inherited genetic mutations, was licensed last December to treat women in Europe with ovarian cancer.
Now trial findings described as "very exciting" have indicated that it could be highly effective at fighting 30% of advanced prostate cancers.
If approved as a new therapy, men would have to undergo genetic testing to qualify for olaparib.
Those eligible would have defects in genes responsible for DNA repair, including BRCA 1 and 2 and ATM.
[Click the title, above, to post a comment.]

Cancer Group Clarifies Confusing Mammography Recommendations

(ABC News) Women between the ages of 40 to 49 should get a mammography to screen for breast cancer if they’ve weighed the risks and benefits, the United States Preventative Services Task Force said in a statement.
“The group’s top level recommendations that women should begin mammogram testing at age 50 and only schedule them every two years until about age 74 have not changed,” Dr. Michael LeFevre, the immediate past chairman of the task force told ABC News. “We’ve also said in the past that the decision to start screening mammography in women prior to age 50 years should be an individual one, he added.
The group wanted to clarify their position on younger women and mammography which he admitted might be confusing for some, said LeFevre.
“Younger women should work with their doctors to balance the pros and cons of mammography and make a determination that best fits their situation and values,” LeFevre said. “There is some small benefit but there is also some risk.”
[Click the title, above, to post a comment.]

Best Ways to Protect Your Heart From Atrial Fibrillation

(Health Hub from Cleveland Clinic) If you’re over 40 and your heart flutters, there’s a good chance you’re one of the millions who suffer from atrial fibrillation (AF). This condition, which can cause the upper chambers of the heart to race for minutes, hours or days, is the product of a malfunction in the heart’s electrical system.
Now, there’s good news that taking control of certain risk factors for heart disease may prevent AF or lessen its impact…
Obesity is major risk factor for AF.  A new study found that AF often disappears in obese patients who lose weight.  The more extra pounds they lose, the more likely their AF will resolve…
High blood pressure, diabetes, heart failure and sleep apnea are other risk factors for AF. Recent studies have shown that aggressive, medically monitored lifestyle changes that significantly lower weight and blood pressure and improve blood sugar control can reduce the risk of developing AF. That’s better than trying to treat AF, say Cleveland Clinic researchers.
[Click the title, above, to post a comment.]

Depression: 'Mindfulness-based therapy shows promise'

(BBC News) A mindfulness-based therapy could offer a "new choice for millions of people" with recurrent depression, a Lancet report suggests.
Scientists tested it against anti-depressant pills for people at risk of relapse and found it worked just as well.
The therapy trains people to focus their minds and understand that negative thoughts may come and go.
In England and Wales doctors are already encouraged to offer it.
[Click the title, above, to post a comment.]

Drugs that activate brain stem cells may reverse multiple sclerosis

(National Institute of Neurological Disorders and Stroke) Two drugs already on the market — an antifungal and a steroid — may potentially take on new roles as treatments for multiple sclerosis… [R]esearchers discovered that these drugs may activate stem cells in the brain to stimulate myelin producing cells and repair white matter, which is damaged in multiple sclerosis.
[Click the title, above, to post a comment.]